BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Chromos Molecular Systems Inc. Releases Fiscal 2005 Results

  April 3, 2006

   · 

  4 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Release: Preclinical Studies Presented At American Association for Cancer Research Meeting Show Potential Of Peregrine Pharmaceuticals, Inc.'s Tarvacin(TM) Plus Radiation Or Chemotherapy To Increase Survival In Resistant Br

  April 3, 2006

   · 

  9 min read
• Drug Development

  Eli Lilly and Company Release: CATIE Phase 2 Data Confirm Patients Stay On Treatment Longer Because Of Symptom Improvement More So Than Tolerability

  April 3, 2006

   · 

  7 min read
• Business

  Australia’s Ventracor Limited Expands Global Reach

  April 3, 2006

   · 

  2 min read
• Business

  Ingen Technologies, Inc. & NEOTECH To Enter Into Negotiations For OxyView Distribution

  April 3, 2006

   · 

  4 min read
• Business

  ThermoGenesis Release: Dr. John Chapman Named Vice President Of Scientific Affairs

  April 3, 2006

   · 

  3 min read
• Drug Development

  EntreMed, Inc. Presents Preclinical Results At American Association for Cancer Research For Panzem(R) And ENMD-1198

  April 3, 2006

   · 

  5 min read
• Drug Development

  Alba Therapeutics Corporation Completes Phase I For AT-1001

  April 3, 2006

   · 

  1 min read
• Biotech Bay

  Sirna Therapeutics, Inc. Granted First Broad siRNA Patent For A Gene Target In The United States

  April 3, 2006

   · 

  4 min read
• Business

  SpectraScience, Inc. Receives Facility Approval From The FDA

  April 3, 2006

   · 

  1 min read